Yahoo! JAPAN

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious ...

2020/3/26 -Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved ZEPOSIA ® (ozanimod) 0.92 ...

About us ; Website: http://www.bms.com. External link for Bristol Myers Squibb ; Industry: Pharmaceutical Manufacturing ; Company size: 10,001+ employees.

2024/1/8 -Delivers free health and wellness education programs on exercise, nutrition, symptom management and motivation to help families living with MS ...

2023/10/11 -BMS Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple ...

2024/3/4 -Contact Bristol Myers Squibb through our contact form, customer relations line or live chat. For product side-effect inquiries call (800) ...

[BMS] happy century. 2007/12/26. 2,027. 23. 1. 25. BMS:http://m-mikiya. ... http://fz.bms.ms/ · 1:40. [BMS] 2109. 2008 ... ms/ · 2:21.

... MS (BMS). The aim of this study was to investigate the relationship between the cognitive profile of BMS patients and the extent of tissue damage in the CC.

We deliver the most advanced digital business services to help the world's best brands to adapt their business in meaningful and sustainable ways.

Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.